Mitsubishi Tanabe Pharma America Inc. clinical trials

A country office of Tanabe Pharma Corporation

The registry lists 7 studies whose lead sponsor is Mitsubishi Tanabe Pharma America Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 15, 2023.

Studies

Recruiting first, then most recently updated. Showing 7 of 7. All Tanabe Pharma Corporation studies →

• Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic FunctionCompletedNCT04116476Phase 1

  Sponsor listed in the registry: Mitsubishi Tanabe Pharma America Inc.

• Mass Balance Study With MT-7117CompletedNCT03503266Phase 1

  Sponsor listed in the registry: Mitsubishi Tanabe Pharma America Inc.

• Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy SubjectsCompletedNCT05241535Phase 1

  Sponsor listed in the registry: Mitsubishi Tanabe Pharma America Inc.

• Relative Bioavailability and Drug-drug Interaction Study With MT-7117 and a Proton Pump InhibitorCompletedNCT03688022Phase 1

  Sponsor listed in the registry: Mitsubishi Tanabe Pharma America Inc.

• PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal FunctionCompletedNCT04656795Phase 1

  Sponsor listed in the registry: Mitsubishi Tanabe Pharma America Inc.

• Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy SubjectsCompletedNCT04793295Phase 1

  Sponsor listed in the registry: Mitsubishi Tanabe Pharma America Inc.

• Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord InjuryCompletedNCT04096950Phase 1

  Sponsor listed in the registry: Mitsubishi Tanabe Pharma America Inc.